Eli Lilly has voiced opposition to proposed tariffs on pharmaceutical products, cautioning that such measures could increase costs, limit patient access, and weaken US leadership in biopharmaceutical innovation.
Biopharmaceutical Innovation | 16/08/2025 | By Dineshwori
VectorBuilder Signs Deal with Sartorius to Advance Biopharmaceutical Innovation
The collaboration will focus on gene vector and mRNA bioprocess solutions and services, accelerating the development and clinical translation of innovative biopharmaceutical projects.
Biopharmaceutical Innovation | 29/11/2024 | By Aishwarya | 178
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy